Cargando…

Clinicopathologic Characteristics and Survival of Patients With Bone Metastasis in Yazd, Iran: A Cross-Sectional Retrospective Study

To evaluate the clinico-pathological and survival characteristics in patients with bone metastasis. This cross-sectional study was conducted on patients with bone metastasis who referred to Shahid Ramezanzadeh radiation oncology center. For all of the patients studied, demographic and survival infor...

Descripción completa

Detalles Bibliográficos
Autores principales: Shabani, Masood, Binesh, Fariba, Behniafard, Nasim, Nasiri, Faezeh, Shamsi, Farimah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603093/
https://www.ncbi.nlm.nih.gov/pubmed/25526486
http://dx.doi.org/10.1097/MD.0000000000000317
_version_ 1782394861541916672
author Shabani, Masood
Binesh, Fariba
Behniafard, Nasim
Nasiri, Faezeh
Shamsi, Farimah
author_facet Shabani, Masood
Binesh, Fariba
Behniafard, Nasim
Nasiri, Faezeh
Shamsi, Farimah
author_sort Shabani, Masood
collection PubMed
description To evaluate the clinico-pathological and survival characteristics in patients with bone metastasis. This cross-sectional study was conducted on patients with bone metastasis who referred to Shahid Ramezanzadeh radiation oncology center. For all of the patients studied, demographic and survival information was recorded. SPSS was used to analyze the data. In this study, 89 men (53.3%) and 78 women (46.7%) with bone metastasis were examined. Most of the patients were in the 66 to 87 age range. Breast cancer was the most common type of cancer in women and prostate cancer was the commonest in men. In most patients, pain was the first manifestation of the disease, and the spine has been most frequently involved areas. The disease was diagnosed by isotope bone scan in the most cases. The mean survival was 31.1 months for patients with breast cancer, 12.9 months for patients with prostate cancer, 13.7 months for patients with lung cancer and the overall survival was 22.5. There was only a meaningful correlation between sex, type of cancer, radiation dose, and survival in patients. We found that age was more effective than the variable of cancer type in survival of patients with bone metastasis. The prognosis of patients with bone metastasis in our center is fair. There was a significant correlation between sex, type of cancer, radiation dose, and survival. Cox proportional hazards model showed that age was a predictor of death.
format Online
Article
Text
id pubmed-4603093
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-46030932015-10-27 Clinicopathologic Characteristics and Survival of Patients With Bone Metastasis in Yazd, Iran: A Cross-Sectional Retrospective Study Shabani, Masood Binesh, Fariba Behniafard, Nasim Nasiri, Faezeh Shamsi, Farimah Medicine (Baltimore) 5700 To evaluate the clinico-pathological and survival characteristics in patients with bone metastasis. This cross-sectional study was conducted on patients with bone metastasis who referred to Shahid Ramezanzadeh radiation oncology center. For all of the patients studied, demographic and survival information was recorded. SPSS was used to analyze the data. In this study, 89 men (53.3%) and 78 women (46.7%) with bone metastasis were examined. Most of the patients were in the 66 to 87 age range. Breast cancer was the most common type of cancer in women and prostate cancer was the commonest in men. In most patients, pain was the first manifestation of the disease, and the spine has been most frequently involved areas. The disease was diagnosed by isotope bone scan in the most cases. The mean survival was 31.1 months for patients with breast cancer, 12.9 months for patients with prostate cancer, 13.7 months for patients with lung cancer and the overall survival was 22.5. There was only a meaningful correlation between sex, type of cancer, radiation dose, and survival in patients. We found that age was more effective than the variable of cancer type in survival of patients with bone metastasis. The prognosis of patients with bone metastasis in our center is fair. There was a significant correlation between sex, type of cancer, radiation dose, and survival. Cox proportional hazards model showed that age was a predictor of death. Wolters Kluwer Health 2014-12-02 /pmc/articles/PMC4603093/ /pubmed/25526486 http://dx.doi.org/10.1097/MD.0000000000000317 Text en © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0, where it is permissible to download, share and reproduce the work in any medium, provided it is properly cited. The work cannot be changed in any way or used commercially. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle 5700
Shabani, Masood
Binesh, Fariba
Behniafard, Nasim
Nasiri, Faezeh
Shamsi, Farimah
Clinicopathologic Characteristics and Survival of Patients With Bone Metastasis in Yazd, Iran: A Cross-Sectional Retrospective Study
title Clinicopathologic Characteristics and Survival of Patients With Bone Metastasis in Yazd, Iran: A Cross-Sectional Retrospective Study
title_full Clinicopathologic Characteristics and Survival of Patients With Bone Metastasis in Yazd, Iran: A Cross-Sectional Retrospective Study
title_fullStr Clinicopathologic Characteristics and Survival of Patients With Bone Metastasis in Yazd, Iran: A Cross-Sectional Retrospective Study
title_full_unstemmed Clinicopathologic Characteristics and Survival of Patients With Bone Metastasis in Yazd, Iran: A Cross-Sectional Retrospective Study
title_short Clinicopathologic Characteristics and Survival of Patients With Bone Metastasis in Yazd, Iran: A Cross-Sectional Retrospective Study
title_sort clinicopathologic characteristics and survival of patients with bone metastasis in yazd, iran: a cross-sectional retrospective study
topic 5700
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603093/
https://www.ncbi.nlm.nih.gov/pubmed/25526486
http://dx.doi.org/10.1097/MD.0000000000000317
work_keys_str_mv AT shabanimasood clinicopathologiccharacteristicsandsurvivalofpatientswithbonemetastasisinyazdiranacrosssectionalretrospectivestudy
AT bineshfariba clinicopathologiccharacteristicsandsurvivalofpatientswithbonemetastasisinyazdiranacrosssectionalretrospectivestudy
AT behniafardnasim clinicopathologiccharacteristicsandsurvivalofpatientswithbonemetastasisinyazdiranacrosssectionalretrospectivestudy
AT nasirifaezeh clinicopathologiccharacteristicsandsurvivalofpatientswithbonemetastasisinyazdiranacrosssectionalretrospectivestudy
AT shamsifarimah clinicopathologiccharacteristicsandsurvivalofpatientswithbonemetastasisinyazdiranacrosssectionalretrospectivestudy